BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wawruszak A, Borkiewicz L, Okon E, Kukula-Koch W, Afshan S, Halasa M. Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers (Basel) 2021;13:4700. [PMID: 34572928 DOI: 10.3390/cancers13184700] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Rong Z, Zhang L, Xu Z, Ji J, He J, Liu W, Hou Y, Li K. HiRAND: A novel GCN semi-supervised deep learning-based framework for classification and feature selection in drug research and development. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1047556] [Reference Citation Analysis]
2 Omidkhah N, Hadizadeh F, Abnous K, Ghodsi R. Synthesis, structure activity relationship and biological evaluation of a novel series of quinoline–based benzamide derivatives as anticancer agents and histone deacetylase (HDAC) inhibitors. Journal of Molecular Structure 2022;1267:133599. [DOI: 10.1016/j.molstruc.2022.133599] [Reference Citation Analysis]
3 Yu SJ, Bajagai YS, Petranyi F, de las Heras-saldana S, Van TTH, Stanley D. Phytogenic Blend Improves Intestinal Health and Reduces Obesity, Diabetes, Cholesterol and Cancers: A Path toward Customised Supplementation. Antibiotics 2022;11:1428. [DOI: 10.3390/antibiotics11101428] [Reference Citation Analysis]
4 Feng J, Meng X. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. Front Pharmacol 2022;13:946811. [DOI: 10.3389/fphar.2022.946811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pramanik SD, Kumar Halder A, Mukherjee U, Kumar D, Dey YN, R M. Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer. Front Chem 2022;10:948217. [DOI: 10.3389/fchem.2022.948217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Caldiran FY, Cacan E. RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154007] [Reference Citation Analysis]
7 Korfei M, Mahavadi P, Guenther A. Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option. Cells 2022;11:1626. [DOI: 10.3390/cells11101626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wawruszak A, Luszczki J, Czerwonka A, Okon E, Stepulak A. Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells. Cells 2022;11:1211. [PMID: 35406775 DOI: 10.3390/cells11071211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang W, Lu L, Sun Y, Dong Z, Lei X, Peng Z, Zhang B, Cao S, Wang X, Pan X, Lau ATY. New Wenshen Shengjing Decoction Improves Early Embryonic Development by Maintaining Low Levels of H3K4me3 in Sperm. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/9775473] [Reference Citation Analysis]
10 Alwash AH, Naser NH. Synthesis, characterization, and vitro evaluation of new materials in vorinostat analogs containing biomolecules. Materials Today: Proceedings 2022;60:1424-1439. [DOI: 10.1016/j.matpr.2021.11.016] [Reference Citation Analysis]
11 Borkiewicz L. Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer. Int J Mol Sci 2021;22:12853. [PMID: 34884658 DOI: 10.3390/ijms222312853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]